Written question asked by Julian Huppert (Liberal Democrat) on Monday, 25 November 2013, in the House of Commons. It was due for an answer on Thursday, 28 November 2013 (named day). It was answered by Lord Willetts (Conservative) on Thursday, 28 November 2013 on behalf of the Department for Business, Innovation and Skills.
Respiratory System: Diseases
- Question
-
To ask the Secretary of State for Business, Innovation and Skills what recent discussions he has had with Novartis to encourage them to maintain respiratory research in the UK.
- Answer
-
Ministers and officials in the Government have regular contact with Novartis and other pharmaceutical investors and discussions cover a range of policy issues.
I met with senior representatives from Novartis on 30 October to discuss the potential changes to their research operations in the UK, which are currently under consultation. Novartis have noted that the proposed changes are a result of a global review of their research activities.
The Department remains in close contact with Novartis regarding the impact of these proposed changes.
Secondary information
- Type
- Written question
- Reference
- 177575; 571 c384W
- Session
- 2013-14
- Subjects
- Diseases Research Respiratory system Novartis
- Link
- View this Written question on www.publications.parliament.uk
Librarians' tools
- Timestamp
- 2023-11-27 11:16:01 +0000
- URI
- http://hansard.intranet.data.parliament.uk/Commons/2013-11-28/13112883000210
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://hansard.intranet.data.parliament.uk/Commons/2013-11-28/13112883000210
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://hansard.intranet.data.parliament.uk/Commons/2013-11-28/13112883000210